2015 BPD Header

Cambridge Healthtech Institute’s 11th Annual
Optimizing Cell Culture Technology
Enhancing Knowledge for Growing Cells
August 3-4, 2015
Part of CHI's 7th Annual The Bioprocessing Summit

August 3-7, 2015 | Westin Copley Place Hotel | Boston, Massachusetts


Preliminary Agenda 

This leading cell culture meeting explores today’s evolving strategies and technologies for improving mammalian cell cultivation, including omics technologies and Synthetic Biology. Industry experts offer insights into optimizing conditions, as well as, cell biology in an effort to improve yield, while also addressing where cell culture is heading as it meets ever greater production demands and quality standards.

The agenda again features a session focused on CHO (Chinese Hamster Ovary cells), as well as small-group breakout discussions that provide the opportunity to discuss important topics with your peers from around the world.


CULTURING CHO CELLS

OPENING KEYNOTE PRESENTATION:
Getting to the Root of the Problem: What are the Fundamental Factors Limiting Growth and Productivity In CHO Cell Cultures?

Gregory Hiller, Ph.D., Associate Research Fellow, Culture Process Development, BioProcess R&D, Pfizer, Inc.

Development and Manufacturability Assessment of Chemically-Defined Medium for the Production of Protein Therapeutics in CHO Cells

Wai Lam W. Ling, Ph.D., Process Development & Engineering, Biologics BioProcess Development, Merck Research Labs

Host Cell Protein Expression during Extended CHO Cell Culture

Kristin Valente, Ph.D., Associate Principal Scientist, Merck


OPTIMIZING PROCESS DEVELOPMENT

FEATURED PRESENTATION:

Tiffany Rau, Ph.D., Global Technical and Technology Manager, Eli Lilly and Company

Novel Virus-Like Particle and Nanoparticle Vaccine Production – An Overview of Cell Culture Process Development

Payal Biswas, PhD, Scientist, Upstream Process Development, Vaccine Production Program, Vaccine Research Center/NIAID/NIH

Enhanced Process Consistency, Robustness and Success in Cell Line Selection Using High-Throughput Bioreactors

Wenqi Xie, Associate Scientist II, Cell Culture Development, Biogen Idec

Biologics Data Platform for Tailored Support of Cell Line Development

Christian Bender, Ph.D., Computational Biologist, Global Drug Discovery, Global Biologics, Bayer HealthCare


PERFUSION VERSUS FED-BATCH PRODUCTION

Prediction of Cell Culture Performance and Molecule Quality Attributes from Micro-Scale Fed-Batch Cultures

Matthieu Stettler, Ph.D., Manager, Biotech Process Sciences – Biosimilars, Global Manufacturing & Supply, Merck Serono

Comparing Antibody Production Using Both Fed-Batch and Perfusion Methods

Daryl Powers, Ph.D., Senior Scientist, Early Cell Culture Development, Sanofi Global Biotherapeutics

Scale-Down Tools for Evaluation of Perfusion Cultivations

Martin Heitmann, Ph.D., Senior Scientist, Cell Culture Technology, Novo Nordisk A/S

Optimizing Osmolality and Cell Expansion Strategy to Improve Cell Culture Performance in a Perfusion-Based Bioreactor Process

Christopher Rives, Ph.D., Senior Upstream Development Engineer, BioProcess Development, Shire Plc


TOOLS & TECHNOLOGIES TO ENHANCE CELL CULTURE PROCESSES

Portable X-ray Fluorescence Spectrometer: A Tool For Biopharmaceutical Forensic Investigations

Jessica Mondia, Ph.D., Research Scientist, Biogen Idec, Inc.

 




For more details on the conference, please contact:
Mary Ruberry
Senior Conference Director
Phone: 781-972-5421
Email: mruberry@healthtech.com 

For exhibit & sponsorship opportunities, please contact: 

Companies A-K:
Elizabeth Lemelin
Business Development Manager
Phone: 781-972-1342
Email: elemelin@healthtech.com 

Companies L-Z:
Sherry Johnson
Business Development Manager
Phone: 781-972-1359
Email: sjohnson@healthtech.com